Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
myProteus Limited, headquartered in Great Britain, is a leading innovator in the biotechnology sector, specialising in advanced proteomics and biomarker discovery. Founded in 2015, the company has rapidly established itself as a key player in the life sciences industry, with a focus on enhancing drug development and personalised medicine.
With a strong presence in Europe and North America, myProteus offers unique services that leverage cutting-edge technologies to provide comprehensive proteomic analysis. Their core products, including proprietary software and analytical tools, are designed to deliver precise insights that drive research and clinical applications.
Recognised for its commitment to quality and innovation, myProteus Limited has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical companies and research institutions worldwide.
-15 vs industry average
myProteus Limited’s score of 21 is lower than 23% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Business Services has below-average carbon intensity
The Business Services industry has reduced its overall emissions by 25% since 2018
No reported emissions data is available for myProteus Limited yet.
myProteus Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that myProteus Limited may still be in the early stages of developing its climate commitments or may not have publicly disclosed its emissions profile.
As the company navigates the evolving landscape of corporate sustainability, it may consider establishing measurable targets aligned with industry standards, such as those set by the Science Based Targets initiative (SBTi), to enhance its climate strategy. Engaging in initiatives like the Carbon Disclosure Project (CDP) or committing to renewable energy through RE100 could further strengthen its environmental commitments.
In summary, myProteus Limited currently lacks specific emissions data and reduction initiatives, highlighting an opportunity for the company to develop a robust climate action plan in line with global sustainability efforts.
No climate goals have been disclosed for myProteus Limited yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more